Privacy
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves nogapendekin alfa inbakicept plus BCG for papillary-only BCG-unresponsive NMIBC
2
Urocross Expander System enters US commercial use for symptomatic BPH
3
Study compares PSMA-PET radiopharmaceuticals in prostate cancer recurrence
4
Study assesses real-world outcomes with intranasal vardenafil for ED
5
